| Net loss | -10.79M |
| Depreciation and amortization | 9.2M |
| Share-based payment compensation | |
| Amortization of deferred revenue | -64K |
| Amortization of debt discount | |
| Amortization of deferred finance costs | 410K |
| Asset impairments and write-offs | |
| Debt extinguishment | |
| Gain on the disposal of equipment | |
| Accounts receivable, net | 25.36M |
| Inventories, net | -15.35M |
| Prepaid expenses and other | 645K |
| Accounts payable and accrued liabilities | 826K |
| Accrued dividends payable — Series B Preferred Stock | |
| Net cash provided by (used for) operating activities | 12.27M |
| Property and equipment additions | -7.31M |
| Change in restricted cash and investments | 0 |
| Proceeds from disposal of equipment | |
| Net cash used for investing activities | -7.31M |
| Payments for Series B Preferred Stock and other issuance costs | |
| Payment for Series B Preferred stock redemption | |
| Payment for Series B Preferred stock dividend | |
| Payments for deferred issuance costs | -1.43M |
| Proceeds from exercise of stock options | 0 |
| Procceeds from issuance of common stock, net | 10M |
| Net cash provided by (used for) financing activities | 22.83M |
| Net increase (decrease) in cash and cash equivalents | 27.78M |
| BEGINNING CASH AND CASH EQUIVALENTS | 11.9M |
| ENDING CASH AND CASH EQUIVALENTS | 39.68M |
| Interest paid | 3.36M |
| Income taxes paid | 51K |
| Property and equipment purchases included in accounts payable | |
| Deferred financing costs included in accrued liabilities | |
| Issuance of 689,655 shares of common stock | |